Literature DB >> 21146831

Factors associated with a prolonged QT interval in liver cirrhosis patients.

Ioana Mozos1, Camelia Costea, Corina Serban, Lelia Susan.   

Abstract

AIM: The aim of this study was to identify factors associated with prolonged QT interval in liver cirrhosis patients.
MATERIALS AND METHODS: Thirty-eight patients with liver cirrhosis were enrolled in this study. The maximal QT interval (QTmax), heart rate-corrected QT interval (QTc), QT interval in lead DII (QTII), and mean QT interval (QTm) were determined manually, using 12-lead electrocardiogram. Additional laboratory tests were also performed.
RESULTS: The following values were obtained: QTmax, 435 ± 43 milliseconds; QTc, 493 ± 46 milliseconds; QT interval in lead DII, 405 ± 46 milliseconds; and mean QT interval, 400 ± 40 milliseconds. Ten (6%) patients had a prolonged QTmax, and 27 (71%) had a prolonged QTc. The highest values were obtained for QTc and QTmax in patients with alcoholic cirrhosis and Child-Pugh class C, respectively. A moderate correlation was observed between QTmax and serum uric acid (URCA; r = 0.504), and multiple linear regression analysis revealed that URCA was significantly associated with QTc and heart rate.
CONCLUSIONS: Liver disease severity, alcoholic etiology, and URCA are associated with prolonged QT interval in patients with liver cirrhosis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146831     DOI: 10.1016/j.jelectrocard.2010.10.034

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  10 in total

Review 1.  Arrhythmia risk in liver cirrhosis.

Authors:  Ioana Mozos
Journal:  World J Hepatol       Date:  2015-04-08

2.  QTc prolongation in patients of cirrhosis and its relation with disease severity: An observational study from a rural teaching hospital.

Authors:  Abhinav Bhardwaj; Sandeep Joshi; Ruby Sharma; Sakshi Bhardwaj; Rishabh Agrawal; Nitin Gupta
Journal:  J Family Med Prim Care       Date:  2020-06-30

3.  The relation between QT interval and T-wave variables in hypertensive patients.

Authors:  Ioana Mozos; Corina Serban
Journal:  J Pharm Bioallied Sci       Date:  2011-07

4.  QTc Prolongation in Veterans With Heroin Dependence on Methadone Maintenance Treatment.

Authors:  Sameer Hassamal; Antony Fernandez; Hossein Moradi Rekabdarkolaee; Ananda Pandurangi
Journal:  Int J High Risk Behav Addict       Date:  2015-06-20

5.  Sex-specific association between serum uric acid and prolonged corrected QT interval: Result from a general rural Chinese population.

Authors:  Xiaofan Guo; Zhao Li; Yamin Liu; Shasha Yu; Hongmei Yang; Liqiang Zheng; Yonghong Zhang; Yingxian Sun
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

6.  Q-T interval prolongation in cirrhosis: Relationship and severity.

Authors:  Ali-Akbar Hajiaghamohammadi; Mohammad-Mahdi Daee; Ali Zargar; Somayeh Ahmadi-Gooraji; Alfred Rahban; Fereshte Attaran
Journal:  Caspian J Intern Med       Date:  2018

Review 7.  Acquired long QT syndrome in chronic kidney disease patients.

Authors:  Peng Liu; Lu Wang; Dan Han; Chaofeng Sun; Xiaolin Xue; Guoliang Li
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

8.  Prevalence of prolonged QT interval in patients with HCV-related chronic liver disease.

Authors:  Ahmed E Gaafar; Amr Abd El-Aal; Mohamed Alboraie; Housam M Hassan; Adel ElTahan; Yasser AbdelRahman; Mohamed-Naguib Wifi; Dalia Omran; Shimaa Afify Mansour; Waleed M Hassan; Magdy Ismail; Mohamed El Kassas
Journal:  Egypt Heart J       Date:  2019-09-07

9.  Model based estimation of QT intervals in non-invasive fetal ECG signals.

Authors:  Namareq Widatalla; Yoshiyuki Kasahara; Yoshitaka Kimura; Ahsan Khandoker
Journal:  PLoS One       Date:  2020-05-11       Impact factor: 3.240

10.  Evidence of Ventricular Arrhythmogenicity and Cardiac Sympathetic Hyperinnervation in Early Cirrhotic Cardiomyopathy.

Authors:  Shin-Huei Liu; Li-Wei Lo; Yu-Hui Chou; Wei-Lun Lin; Tsung-Ying Tsai; Wen-Han Cheng; Yenn-Jiang Lin; Shih-Lin Chang; Yu-Feng Hu; Fa-Po Chung; Hui-Chun Huang; Shih-Ann Chen
Journal:  Front Physiol       Date:  2021-12-08       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.